Effects of Clinical Pilates on Physical and Psychosocial Outcomes in Individuals With Interstitial Lung Disease

Starting soon · Not applicable

Conditions studied: Interstitial Lung Disease (ILD)

In brief

This study aims to investigate the effects of Clinical Pilates on physical and psychosocial outcomes in individuals with interstitial lung disease (ILD). Interstitial lung disease is a group of chronic conditions that affect lung tissue and can lead to breathing difficulties, reduced physical capacity, fatigue, and decreased quality of life. In addition to medical treatment, exercise-based rehabilitation approaches may help individuals with ILD improve their physical function and overall well-being. Clinical Pilates is a structured exercise method that focuses on breathing control, posture, core stability, flexibility, and body awareness. Participants in this study will be randomly assigned to either a Clinical Pilates group or a control group receiving standard care. The Clinical Pilates program will be delivered by a trained physiotherapist over several weeks through supervised sessions. The main outcomes of this study include physical function, respiratory symptoms, quality of life, and psychological well-being. The results of this study are expected to provide evidence on whether Clinical Pilates can be an effective and safe supportive approach for pulmonary rehabilitation in individuals with interstitial lung disease.

Key facts

Study ID

NCT07411066

Run by

Recep Tayyip Erdogan University

People needed

58

Starts

2026-02-01

Expected to finish

2026-05-01

Last updated by the study team

2026-02-13

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 to 75 years.
• Clinically confirmed diagnosis of interstitial lung disease (ILD) by a physician.
• Clinically stable condition (no acute exacerbation or hospitalization related to ILD within the last 4 weeks).
• On stable medical treatment and routine follow-up.
• Able to walk and participate in low-to-moderate intensity exercise as determined by the clinician/physiotherapist.
• Able to understand study procedures and provide written informed consent.

You may not qualify if…

• Coexisting chronic respiratory disease that may confound outcomes (e.g., COPD, uncontrolled asthma, bronchiectasis).
• Acute exacerbation of ILD or hospitalization within the last 4 weeks.
• Unstable cardiovascular disease or other medical conditions making exercise unsafe (e.g., unstable angina, recent myocardial infarction).
• Severe neurological, musculoskeletal, or balance disorders limiting safe participation in exercise.
• Pulmonary hypertension or oxygen dependency requiring unstable/high-flow support if judged unsafe for exercise participation by the treating clinician.
• Current participation in another structured exercise / pulmonary rehabilitation program during the study period.
• Major psychiatric disorder or cognitive impairment interfering with participation or adherence.
• Pregnancy.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.